Biohit HealthCare (Hefei) Co., Ltd. has been invited to attend the COVID-19 Drug and Diagnostic Developments Virtual Conference held on July 11th 2020, 9:00 am – 6:00 pm CET. The company would have a keynote presentation on the topic of “Serology Testing of Antigen and Antibody for SARS-CoV-2” in the conference, which starts from 9:15 am CET, discussing the latest findings on serological diagnosis. Held by Sciinov Group, the conference includes scholars from renown universities all over the world as well as famous biotech companies from Europe, the United States and Brazil. Biohit is honor to be the only Chinese enterprises being invited to this conference. Under the pressing world pandemic, Biohit hopes to dedicate in promoting innovative diagnostic development on COVID-19.
For more information, please visit: